REGENCELL BIOSCIENCE HOLDINGS LIMITED
RGCLoading price...
Overview
Previous Close20.45
Open20.49
Ask24.62
Bid14.67
Day's Range18.80 - 20.68
52 Week Range9.39 - 83.60
PE Ratio(TTM)--
Market Cap9.67B
Volume69.12k
Avg. Volume129.06k
12 Months Earnings-7.05M
12 Months Revenue0.00
Profit/Loss
| PARTICULARS | TTM | 2024 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 7.13M | 4.40M | 4.74M | 6.27M | 7.62M | 1.38M |
| Profit after Tax (Net Income) | -7.05M | -4.09M | -4.30M | -5.87M | -7.45M | -1.35M |
Company Profile
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
HQ Location: Causeway Bay, Hong Kong
Website: https://www.regencellbioscience.com
Founder, Chairman & CEO: Mr. Yat-Gai Au
Employees: 10
About Company:
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.